A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function...

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Inherited mutations in BRCA1 and BRCA2 genes are linked to dominant cancer susceptibility.
• These genes are crucial for the homology-directed DNA repair pathway.
• The study explores if other DNA repair pathway genes also influence cancer susceptibility.

Purpose of the Study:

• To investigate whether mutations in other genes involved in the homology-directed DNA repair pathway can affect cancer susceptibility.
• To identify and characterize novel variants in the XRCC3 gene, a component of this pathway.

Main Methods:

• Sequencing of the XRCC3 gene to identify novel non-synonymous substitutions.
• Functional analysis of a specific variant (D213N) in XRCC3-deficient cells.
• Genotyping of healthy individuals and cancer patient cohorts for the presence of the D213N variant.

Main Results:

• Three novel non-synonymous substitutions were identified in the XRCC3 gene.
• The D213N variant, located in a conserved ATP-binding domain, completely abolished the DNA repair function in XRCC3-deficient cells.
• The D213N variant was found in 3 out of 1577 healthy individuals but was not detected in 187 breast cancer families or 1300 unselected cancer patients.

Conclusions:

• The study found no evidence that the XRCC3 D213N variant increases cancer risk.
• The findings suggest that not all components of the homologous recombination repair complex may function as cancer susceptibility genes.